Delivery Order SPE2DB20D3103-SPE2DB25FP8Y4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,417.53 to AmerisourceBergen Drug Corp for the supply of Mercaptopurine 50 mg tablets (250 count) under a firm fixed-price contract. The award was made on August 18, 2025, with an ultimate completion date of August 19, 2025, and is classified as a non-set-aside competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mercaptopurine 50 mg tablets (250-count units) with a ceiling value of $11,142.08. This firm fixed-price delivery order, which is expected to be completed by July 29, 2025, represents a non-competitive set-aside transaction and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Mercaptopurine is an antimetabolite medication commonly used in cancer...
- This is a $2,211.36 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 250-count bottles of the drug mercaptopurine 50 mg tablets. The contract has an ultimate completion date of May 23, 2025 and is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order on August 11, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,275.62. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units, with a ceiling value of $1,109.30. This is a firm fixed price delivery order with an ultimate completion date of August 8, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Azathioprine 50 mg tablets (100-count units) with a ceiling value of $1,805.45. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract has an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Azathioprine 50 mg tablets in quantities of 100 units at a ceiling value of $2,056.22. This non-competitive, firm fixed-price delivery order is set to be completed by August 4, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement under the company's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Azathioprine 50 mg tablets (100-count) under a firm fixed-price contract valued at $3,469.06. This is a non-set-aside award issued as a child delivery order, with performance at the contractor's Conshohocken, Pennsylvania facility and an ultimate completion date of August 12, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $4,451.80 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $7,277.80 to AmerisourceBergen Drug Corp for Qualipita 60 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was competitively selected to...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP8Y4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Mercaptopurine 50 mg tablets (250-count units) with a ceiling value of $1,842.80. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the company's established capability to meet federal pharmaceutical procurement requirements. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems, the Defense Health Agency, and other government healthcare entities. The company's portfolio includes brand-name and generic pharmaceuticals, vaccines, and specialized medical commodities across multiple therapeutic domains, positioning it as a key provider within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/14/25 |